文献速递神经核医学

非专家核医学医师对早期未用药帕金森病[123I]FP-CIT SPECT视觉评估的可靠性及神经科转诊指征调查

Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [123I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson's disease.
PubMed 文献 · EJNMMI Res · 2019-07-24

该研究基于LEAP试验入组前常规临床获取的[123I]FP-CIT SPECT图像,由DAT显像专家重新评估并与初始本地评估对比,同时向转诊神经科医师发放DAT SPECT使用调查问卷。结果显示初始本地评估与专家复评的一致率为98.7%,但仅73.6%的转诊是为了鉴别神经退行性与非神经退行性帕金森综合征。提示社区核医学医师视觉评估可靠,但部分神经科医师对DAT SPECT高准确性的适用范围认识不足。

要点

  • 社区核医学医师对早期未用药帕金森病患者的[123I]FP-CIT SPECT视觉评估与专家复评一致率达98.7%。
  • 仅73.6%的神经科医师转诊DAT SPECT是为了鉴别神经退行性与非神经退行性帕金森综合征。
  • 部分转诊医师未充分认识到DAT SPECT高准确性仅限于上述鉴别,不能可靠区分不同帕金森综合征。

核心结论

  • 社区核医学医师对早期未用药帕金森病患者[123I]FP-CIT SPECT的视觉评估与DAT显像专家复评高度一致。
  • 部分请求DAT SPECT的神经科医师未充分意识到其高准确性仅限于鉴别神经退行性与非神经退行性帕金森综合征。

研究设计与样本

  • 收集LEAP试验参与者入组前作为常规临床工作一部分完成的[123I]FP-CIT SPECT扫描,由DAT显像专家重新评估。
  • 向所有转诊神经科医师发放关于DAT SPECT使用情况的调查问卷。

主要发现

  • 初始本地评估与专家复评的一致率为98.7%。
  • 调查显示神经科医师仅在73.6%的患者中为鉴别神经退行性与非神经退行性帕金森综合征而申请DAT SPECT。

临床怎么用

  • 在早期未用药帕金森病患者中,社区核医学医师可依据[123I]FP-CIT SPECT视觉评估提供可靠的DAT显像判读。
  • 神经科医师转诊DAT SPECT时应明确其适用指征为鉴别神经退行性与非神经退行性帕金森综合征,而非区分不同帕金森综合征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the reliability of visual assessment of [123I]FP-CIT SPECT imaging by non-experts in dopamine transporter (DAT) SPECT imaging in patients with early drug-naive Parkinson's disease (PD). Also, we explored the indications of DAT SPECT imaging in clinical practice by neurologists. METHODS: We collected [123I]FP-CIT SPECT scans of the Levodopa in EArly Parkinson's disease (LEAP) trial participants that were made prior to recruitment, as part of routine clinical work-up. All scans were reassessed by an expert in DAT imaging. A survey on the use of DAT SPECT imaging was sent to all referring neurologists. RESULTS: The concordance of the initial local assessment and the expert reassessment was 98.7%. The survey showed that neurologists requested DAT SPECT imaging in only 73.6% of patients to differentiate between a neurodegenerative disease and non-neurodegenerative parkinsonism. CONCLUSIONS: Visual assessment of [123I]FP-CIT SPECT imaging by community nuclear medicine physicians in patients with early PD is reliable. Neurologists who request DAT SPECT scans are not always aware that the high accuracy is limited only to the differentiation between neurodegenerative and non-neurodegenerative parkinsonism. A significant portion of neurologists who request DAT SPECT scans is not always aware that the high accuracy is limited to the differentiation between neurodegenerative and non-neurodegenerative parkinsonism as DAT SPECT cannot reliably distinguish the various Parkinsonian syndromes.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Suwijn SR, Verschuur CVM, Slim MA, et al. Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [123I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson's disease. EJNMMI Res. 2019. PMID: 31342202. doi:10.1186/s13550-019-0537-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。